373110.KQ

Compare

No price history available for this symbol yet.

Fair-value model

Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.

Years of analysisAssumption entries

Analyst estimates unavailable for this ticker.

Held by

portfolios on TandT

Bookmarked by

users

Avg position size

—

of holders' portfolios

13F filers

institutions

Sector

Biotechnology

Peer comparison

Symbol	Price	Today	Mkt cap	P/E
373110.KQXcell Therapeutics, Inc.	$1017.00	-0.10%	$17.6B	—
002630.KSORIENT BIO Inc.	$913.00	+8.69%	$54.1B	—
118000.KSMetacare Co., Ltd.	$1287.00	+1.58%	$22.1B	—
200780.KQBCWORLD PHARM. Co., Ltd.	$3020.00	-0.33%	$30.9B	—
229000.KQGencurix, Inc.	$1957.00	+0.88%	$45.8B	—
464280.KQTdspharm	$5670.00	+2.16%	$30.0B	—

Source: Financial Modeling Prep · peers by sector/industry

Xcell Therapeutics, Inc.

Xcell Therapeutics Inc. engages in the development and production of drugs for cell therapy. It offers CellCor, a serum-free chemically defined medium that is used to develop human mesenchymal stem cells. The company also offers XPorT, a platform that aims to develop optimal media from the perspective of the user using a variety of cells. In addition, it develops media for cell culture in various areas of the bioindustry such as cell therapy, gene therapy, exosomes, organoids and bioreactors. Xcell Therapeutics Inc. was founded in 2015 and is based in Seoul, South Korea.

xcell.co.kr/kor

Employees: 65
IPO / List date: Jul 15, 2024
HQ: KR

Held by traders on TradeandTell

No one on the platform currently holds 373110.KQ.

Super investors & insiders

Institutions holding (13F)

No tracked institution reports a position in 373110.KQ as of their last filing.

Insider activity (SEC Form 4)

No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.

Insider activity (SEC Form 4)

Recent trades on TradeandTell

No one on the platform has traded 373110.KQ yet.